These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30277834)

  • 21. Uropathogenic Escherichia coli mediated urinary tract infection.
    Totsika M; Moriel DG; Idris A; Rogers BA; Wurpel DJ; Phan MD; Paterson DL; Schembri MA
    Curr Drug Targets; 2012 Oct; 13(11):1386-99. PubMed ID: 22664092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uropathogenic Escherichia coli strains harboring tosA gene were associated to high virulence genes and a multidrug-resistant profile.
    Xicohtencatl-Cortes J; Cruz-Córdova A; Cázares-Domínguez V; Escalona-Venegas G; Zavala-Vega S; Arellano-Galindo J; Romo-Castillo M; Hernández-Castro R; Ochoa SA; Luna-Pineda VM
    Microb Pathog; 2019 Sep; 134():103593. PubMed ID: 31195111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple antibiotic resistances and virulence markers of uropathogenic Escherichia coli from Mexico.
    Paniagua-Contreras GL; Monroy-Pérez E; Bautista A; Reyes R; Vicente A; Vaca-Paniagua F; Díaz CE; Martínez S; Domínguez P; García LR; Uribe-García A; Vaca S
    Pathog Glob Health; 2018 Dec; 112(8):415-420. PubMed ID: 30433859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Draft genome sequence of a multidrug-resistant CTX-M-15 β-lactamase-producing uropathogenic Escherichia coli isolate (ST131-O25b-H30) from Pakistan exhibiting high potential virulence.
    Rafaque Z; Dasti JI; Andrews SC
    J Glob Antimicrob Resist; 2018 Dec; 15():164-165. PubMed ID: 30308316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic-resistant ST38, ST131 and ST405 strains are the leading uropathogenic Escherichia coli clones in Riyadh, Saudi Arabia.
    Alghoribi MF; Gibreel TM; Farnham G; Al Johani SM; Balkhy HH; Upton M
    J Antimicrob Chemother; 2015 Oct; 70(10):2757-62. PubMed ID: 26183183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engineered Lactobacillus rhamnosus GG expressing IgG-binding domains of protein G: Capture of hyperimmune bovine colostrum antibodies and protection against diarrhea in a mouse pup rotavirus infection model.
    Günaydın G; Zhang R; Hammarström L; Marcotte H
    Vaccine; 2014 Jan; 32(4):470-7. PubMed ID: 24291196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Host-Derived Nitric Oxide and Its Antibacterial Effects in the Urinary Tract.
    Svensson L; Poljakovic M; Demirel I; Sahlberg C; Persson K
    Adv Microb Physiol; 2018; 73():1-62. PubMed ID: 30262107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of virulence factors and phylogenetic characterization of uropathogenic Escherichia coli causing urinary tract infection in patients with and without diabetes mellitus.
    Harwalkar A; Gupta S; Rao A; Srinivasa H
    Trans R Soc Trop Med Hyg; 2015 Dec; 109(12):769-74. PubMed ID: 26567223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic diversity, virulence genotype and antimicrobial resistance of uropathogenic Escherichia coli (UPEC) isolated from sows.
    Spindola MG; Cunha MPV; Moreno LZ; Amigo CR; Silva APS; Parra BM; Poor AP; de Oliveira CH; Perez BP; Knöbl T; Moreno AM
    Vet Q; 2018 Dec; 38(1):79-87. PubMed ID: 30362902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition and Inactivation of Uropathogenic
    Narayanan A; Nair MS; Muyyarikkandy MS; Amalaradjou MA
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29880781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uropathogenic Escherichia coli are less likely than paired fecal E. coli to have CRISPR loci.
    Dang TN; Zhang L; Zöllner S; Srinivasan U; Abbas K; Marrs CF; Foxman B
    Infect Genet Evol; 2013 Oct; 19():212-8. PubMed ID: 23891665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary tract infection: Pathogenicity, antibiotic resistance and development of effective vaccines against Uropathogenic Escherichia coli.
    Asadi Karam MR; Habibi M; Bouzari S
    Mol Immunol; 2019 Apr; 108():56-67. PubMed ID: 30784763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent urinary tract infections in women: risk factors, etiology, pathogenesis and prophylaxis.
    Guglietta A
    Future Microbiol; 2017 Mar; 12():239-246. PubMed ID: 28262045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MOLECULAR CHARACTERIZATION OF VIRULENCE AND ANTIMICROBIAL SUSCEPTIBILITY PROFILES OF UROPATHOGENIC ESCHERICHIA COLI FROM PATIENTS IN A TERTIARY HOSPITAL, SOUTHERN THAILAND.
    Themphachanal M; Kongpheng S; Rattanachuay P; Khianngam S; Singkhamanan K; Sukhumungoon P
    Southeast Asian J Trop Med Public Health; 2015 Nov; 46(6):1021-30. PubMed ID: 26867360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "Population structure of drug-susceptible,-resistant and ESBL-producing Escherichia coli from community-acquired urinary tract".
    Hertz FB; Nielsen JB; Schønning K; Littauer P; Knudsen JD; Løbner-Olesen A; Frimodt-Møller N
    BMC Microbiol; 2016 Apr; 16():63. PubMed ID: 27067536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dietary flavonoid luteolin attenuates uropathogenic Escherichia. Coli invasion of the urinary bladder.
    Shen XF; Teng Y; Sha KH; Wang XY; Yang XL; Guo XJ; Ren LB; Wang XY; Li J; Huang N
    Biofactors; 2016 Nov; 42(6):674-685. PubMed ID: 27452812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Virulence factors of uropathogenic Escherichia coli of urinary tract infections and asymptomatic bacteriuria in children.
    Yun KW; Kim HY; Park HK; Kim W; Lim IS
    J Microbiol Immunol Infect; 2014 Dec; 47(6):455-61. PubMed ID: 24064288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic resistance, virulence factors and genotyping of Uropathogenic
    Raeispour M; Ranjbar R
    Antimicrob Resist Infect Control; 2018; 7():118. PubMed ID: 30305891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperimmune bovine colostrum as a novel therapy to combat Clostridium difficile infection.
    Sponseller JK; Steele JA; Schmidt DJ; Kim HB; Beamer G; Sun X; Tzipori S
    J Infect Dis; 2015 Apr; 211(8):1334-41. PubMed ID: 25381448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxic Necrotizing Factor-1 (CNF1) does not promote E. coli infection in a murine model of ascending pyelonephritis.
    Michaud JE; Kim KS; Harty W; Kasprenski M; Wang MH
    BMC Microbiol; 2017 May; 17(1):127. PubMed ID: 28545489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.